Prescription Drug Affordability and Access Act

S. 476, the Maintaining Investments in New Innovation Act. S. 3131/ H.R. 5539, the ORPHAN Cures Act. H.R. 5547, the Maintaining Investments in New Innovation Act. No bill number. Discussed implementation of prescription drug provisions of Inflation Reduction Act. S. 150, Affordable Prescriptions for Patients Act of 2023. H.R. 6986, To address patent thickets. H.R. 9070, the Affordable Prescriptions for Patients Act. H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. H.R. 5429, the Medication Affordability and Patent Integrity Act. S. 2780, the Medication Affordability and Patent Integrity Act. S. 4878, the Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. No bill number. Discussed the Medicare Drug Price Negotiation Program Draft Guidance. No bill number. Discussed Medicare Prescription Payment Plan. No bill number. Discussed out-of-pocket caps for prescription drugs. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed Medicare negotiated drug prices. No bill number. Discussed the low-income subsidy Extra Help program. No bill number. Discussed Medicare Part D open enrollment. S. 2973, the Modernizing and Ensuring PBM Accountability Act. S. 142, the Preserve Access to Affordable Generics and Biosimilars Act. S. 4845, the Prescription Drug Affordability and Access Act. S.3311, the American Made Pharmaceuticals Act of 2023.